Leukemia Research
Volume 30, Issue 9 , Pages 1067-1068 , September 2006

Myelodysplastic syndromes: A view from where the sun rises and where the sun sets

  • Rami Komrokji

      Affiliations

    • Corresponding Author InformationHematology/Oncology Division, Barrett Cancer Center, University of Cincinnati, 234 Goodman Avenue, ML 0501, Cincinnati, OH 45267, United States. Tel.: +1 513 584 3830; fax: +1 513 584 0676.

Received 14 April 2006 ,Revised 14 April 2006 ,Accepted 16 April 2006.

References 

  1. Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol. 2000;72:131–133
  2. Irons RD, Wang X, Gross SA, et al. Prevalence of MDS subtypes in Shanghai, China: A comparison of the World Health Organization and French American British classifications. Leuk Res. 2006;30:769–775
  3. Komrokji RS, Bennett JM. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes. Curr Hematol Rep. 2005;4:175–181
  4. Matsuda A, Germing U, Jinnai I, et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood. 2005;106:2633–2640
  5. Lee JH, Lee JH, Shin YR, et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia. 2003;17:305–313
  6. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res. 2000;24:983–992

PII: S0145-2126(06)00148-2

doi: 10.1016/j.leukres.2006.04.004

Leukemia Research
Volume 30, Issue 9 , Pages 1067-1068 , September 2006

Article Tools